已收盤 05-08 16:00:00 美东时间
+0.730
+0.90%
Itron shareholders elect directors at annual meeting Annual shareholder meeting held May 7, 2026. Director nominees were elected, setting board terms running to 2028 for Class 3 seats, 2029 for Class 1 seats. Shareholders backed a non-binding advisory vote on executive compensation. Appointment of D
05-08 18:04
今日重点评级关注:HC Wainwright & Co.:维持Protara Therapeutics"买入"评级,目标价从23美元升至27美元;BTIG:维持Black Diamond Therapeutic"买入"评级,目标价从10美元升至11美元
04-30 19:24
TD Cowen analyst Jeff Osborne maintains Itron (NASDAQ:ITRI) with a Buy and lowers the price target from $145 to $130.
04-30 02:08
华盛资讯4月29日讯,伊管公布2026财年Q1业绩,公司Q1营收5.87亿美元,同比下降3.3%,归母净利润0.53亿美元,同比下滑18.4%。
04-29 01:33
Itron (NASDAQ:ITRI) reported first-quarter financial results on Tuesday. The tr...
04-28 22:58
华盛资讯4月28日讯,伊管公布2026财年Q1业绩,公司Q1营收5.87亿美元,同比下降3.3%,归母净利润0.53亿美元,同比下滑18.5%。
04-28 20:46
Companies Reporting Before The Bell • LGI Homes (NASDAQ:LGIH) is likely to repo...
04-28 19:11
Itron (ITRI) said that on April 13 it was notified that an unauthorized third party gained access to certain of its systems. The company said in a regulatory filing that it took action to remove the u...
04-24 20:59
Itron says unauthorized system access incident not expected to materially impact operations Itron detected unauthorized third-party access to certain systems on April 13, 2026. Cybersecurity response plan was activated, with external advisors engaged for investigation and remediation. Remediation re
04-24 20:32
今日重点评级关注:HC Wainwright & Co.:维持FibroBiologics"买入"评级,目标价从4美元升至8美元;摩根士丹利:维持Ultragenyx药业"超配"评级,目标价从50美元升至67美元
04-17 11:27